Literature DB >> 33573221

Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization.

Yongjun Sui1, Yonas Bekele1, Jay A Berzofsky1.   

Abstract

Both SARS-CoV-2 infections and vaccines induce robust immune responses. Current data suggested that high neutralizing antibody titers with sustained Th1 responses might correlate with protection against viral transmission and disease development and severity. In addition, genetic and innate immune factors, including higher levels of type I interferons, as well as the induction of trained immunity and local mucosal immunity also contribute to lower risk of infection and amelioration of disease severity. The identification of immune correlates of protection will facilitate the development of effective vaccines and therapeutics strategies.

Entities:  

Keywords:  SARS-CoV-2; T-cell immunity; Th1 responses; innate immunity; mucosal immunity; neutralizing antibody; trained immunity; type I interferon

Year:  2021        PMID： 33573221      PMCID： PMC7912691          DOI： 10.3390/pathogens10020138

Source DB:  PubMed          Journal:  Pathogens        ISSN： 2076-0817


  79 in total

1.  SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.

Authors:  Nina Le Bert; Anthony T Tan; Kamini Kunasegaran; Christine Y L Tham; Morteza Hafezi; Adeline Chia; Melissa Hui Yen Chng; Meiyin Lin; Nicole Tan; Martin Linster; Wan Ni Chia; Mark I-Cheng Chen; Lin-Fa Wang; Eng Eong Ooi; Shirin Kalimuddin; Paul Anantharajah Tambyah; Jenny Guek-Hong Low; Yee-Joo Tan; Antonio Bertoletti
Journal:  Nature       Date:  2020-07-15       Impact factor: 49.962

2.  Promise and challenges in the development of COVID-19 vaccines.

Authors:  Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

3.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

Review 4.  Trained immunity: A program of innate immune memory in health and disease.

Authors:  Mihai G Netea; Leo A B Joosten; Eicke Latz; Kingston H G Mills; Gioacchino Natoli; Hendrik G Stunnenberg; Luke A J O'Neill; Ramnik J Xavier
Journal:  Science       Date:  2016-04-21       Impact factor: 47.728

5.  Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients.

Authors:  Jean-Rémi Lavillegrand; Marc Garnier; Agathe Spaeth; Nathalie Mario; Geoffroy Hariri; Antoine Pilon; Enora Berti; Fabienne Fieux; Sara Thietart; Tomas Urbina; Matthieu Turpin; Lucie Darrivere; Muriel Fartoukh; Franck Verdonk; Guillaume Dumas; Alain Tedgui; Bertrand Guidet; Eric Maury; Yannick Chantran; Guillaume Voiriot; Hafid Ait-Oufella
Journal:  Ann Intensive Care       Date:  2021-01-13       Impact factor: 6.925

6.  Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

Authors:  Alicia T Widge; Nadine G Rouphael; Lisa A Jackson; Evan J Anderson; Paul C Roberts; Mamodikoe Makhene; James D Chappell; Mark R Denison; Laura J Stevens; Andrea J Pruijssers; Adrian B McDermott; Britta Flach; Bob C Lin; Nicole A Doria-Rose; Sijy O'Dell; Stephen D Schmidt; Kathleen M Neuzil; Hamilton Bennett; Brett Leav; Mat Makowski; Jim Albert; Kaitlyn Cross; Venkata-Viswanadh Edara; Katharine Floyd; Mehul S Suthar; Wendy Buchanan; Catherine J Luke; Julie E Ledgerwood; John R Mascola; Barney S Graham; John H Beigel
Journal:  N Engl J Med       Date:  2020-12-03       Impact factor: 91.245

7.  Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses.

Authors:  Janine Hensel; Kathleen M McAndrews; Daniel J McGrail; Dara P Dowlatshahi; Valerie S LeBleu; Raghu Kalluri
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

8.  Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.

Authors:  Kevin W Ng; Nikhil Faulkner; Georgina H Cornish; Annachiara Rosa; Ruth Harvey; Saira Hussain; Rachel Ulferts; Christopher Earl; Antoni G Wrobel; Donald J Benton; Chloe Roustan; William Bolland; Rachael Thompson; Ana Agua-Doce; Philip Hobson; Judith Heaney; Hannah Rickman; Stavroula Paraskevopoulou; Catherine F Houlihan; Kirsty Thomson; Emilie Sanchez; Gee Yen Shin; Moira J Spyer; Dhira Joshi; Nicola O'Reilly; Philip A Walker; Svend Kjaer; Andrew Riddell; Catherine Moore; Bethany R Jebson; Meredyth Wilkinson; Lucy R Marshall; Elizabeth C Rosser; Anna Radziszewska; Hannah Peckham; Coziana Ciurtin; Lucy R Wedderburn; Rupert Beale; Charles Swanton; Sonia Gandhi; Brigitta Stockinger; John McCauley; Steve J Gamblin; Laura E McCoy; Peter Cherepanov; Eleni Nastouli; George Kassiotis
Journal:  Science       Date:  2020-11-06       Impact factor: 47.728

9.  A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.

Authors:  Ahmed O Hassan; Natasha M Kafai; Igor P Dmitriev; Julie M Fox; Brittany K Smith; Ian B Harvey; Rita E Chen; Emma S Winkler; Alex W Wessel; James Brett Case; Elena Kashentseva; Broc T McCune; Adam L Bailey; Haiyan Zhao; Laura A VanBlargan; Ya-Nan Dai; Meisheng Ma; Lucas J Adams; Swathi Shrihari; Jonathan E Danis; Lisa E Gralinski; Yixuan J Hou; Alexandra Schäfer; Arthur S Kim; Shamus P Keeler; Daniela Weiskopf; Ralph S Baric; Michael J Holtzman; Daved H Fremont; David T Curiel; Michael S Diamond
Journal:  Cell       Date:  2020-08-19       Impact factor: 66.850

10.  ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.

Authors:  Neeltje van Doremalen; Teresa Lambe; Alexandra Spencer; Sandra Belij-Rammerstorfer; Jyothi N Purushotham; Julia R Port; Victoria A Avanzato; Trenton Bushmaker; Amy Flaxman; Marta Ulaszewska; Friederike Feldmann; Elizabeth R Allen; Hannah Sharpe; Jonathan Schulz; Myndi Holbrook; Atsushi Okumura; Kimberly Meade-White; Lizzette Pérez-Pérez; Nick J Edwards; Daniel Wright; Cameron Bissett; Ciaran Gilbride; Brandi N Williamson; Rebecca Rosenke; Dan Long; Alka Ishwarbhai; Reshma Kailath; Louisa Rose; Susan Morris; Claire Powers; Jamie Lovaglio; Patrick W Hanley; Dana Scott; Greg Saturday; Emmie de Wit; Sarah C Gilbert; Vincent J Munster
Journal:  Nature       Date:  2020-07-30       Impact factor: 49.962
View more
  21 in total

1.  An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques.

Authors:  Yongjun Sui; Jianping Li; Hanne Andersen; Roushu Zhang; Sunaina K Prabhu; Tanya Hoang; David Venzon; Anthony Cook; Renita Brown; Elyse Teow; Jason Velasco; Laurent Pessaint; Ian N Moore; Laurel Lagenaur; Jim Talton; Matthew W Breed; Josh Kramer; Kevin W Bock; Mahnaz Minai; Bianca M Nagata; Hyoyoung Choo-Wosoba; Mark G Lewis; Lai-Xi Wang; Jay A Berzofsky
Journal:  PNAS Nexus       Date:  2022-06-17

2.  How to Evaluate COVID-19 Vaccine Effectiveness-An Examination of Antibody Production and T-Cell Response.

Authors:  Yi-Chen Fu; Ying-Shih Su; Ching-Fen Shen; Chao-Min Cheng
Journal:  Diagnostics (Basel)       Date:  2022-06-06

3.  In vitro study on efficacy of PHELA, an African traditional drug against SARS-CoV-2.

Authors:  M G Matsabisa; K Alexandre; Collins U Ibeji; S Tripathy; Ochuko L Erukainure; K Malatji; S Chauke; B Okole; H P Chabalala
Journal:  Sci Rep       Date:  2022-06-19       Impact factor: 4.996

4.  A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naïve Individuals: A Longitudinal Study in Ethiopian Health Workers.

Authors:  Tesfaye Gelanew; Andargachew Mulu; Markos Abebe; Timothy A Bates; Liya Wassie; Mekonnen Teferi; Dessalegn Fentahun; Aynalem Alemu; Frehiwot Tamiru; Gebeyehu Assefa; Abebe Genetu Bayih; Fikadu G Tafesse; Adane Mihret; Alemseged Abdissa
Journal:  Vaccines (Basel)       Date:  2022-05-27

5.  A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): A consensus of Latin American experts.

Authors:  Fabian F Fay; Carlos Arturo Alvarez-Moreno; Pablo E Bonvehi; Carolina Cucho Espinoza; Marco Luis Herrera Hidalgo; Marcel Marcano-Lozada; Carlos M Perez; Alvaro Pulchinelli; Klever Vinicio Sáenz-Flor; Antonio Condino-Neto
Journal:  Int J Infect Dis       Date:  2021-05-20       Impact factor: 12.074

6.  A single dose ChAdOx1 nCoV-19 vaccine elicits high antibody responses in individuals with prior SARS-CoV-2 infection comparable to that of double dose vaccinated SARS-CoV-2 infection naïve individuals.

Authors:  Tesfaye Gelanew; Andargachew Mulu; Markos Abebe; Timothy A Bates; Liya Wassie; Mekonnen Tefer; Desalegn Fentahun; Aynalem Alemu; Frehiwot Tamiru; Gebeyehu Assefa; Abebe Genetu Bayih; Fikadu G Taffesse; Adane Mihret; Alemseged Abdissa
Journal:  Res Sq       Date:  2022-01-11

7.  Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3-5 months follow-up.

Authors:  Iddo Z Ben-Dov; Yonatan Oster; Keren Tzukert; Talia Alster; Raneem Bader; Ruth Israeli; Haya Asayag; Michal Aharon; Ido Burstein; Hadas Pri-Chen; Ashraf Imam; Roy Abel; Irit Mor-Yosef Levi; Abed Khalaileh; Esther Oiknine-Djian; Aharon Bloch; Dana G Wolf; Michal Dranitzki Elhalel
Journal:  J Nephrol       Date:  2022-01-06       Impact factor: 3.902

Review 8.  Insights into the virologic and immunologic features of SARS-COV-2.

Authors:  Ceylan Polat; Koray Ergunay
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

Review 9.  Population (Antibody) Testing for COVID-19-Technical Challenges, Application and Relevance, an English Perspective.

Authors:  Peter A C Maple
Journal:  Vaccines (Basel)       Date:  2021-05-24

10.  Seroconversion among COVID-19 patients admitted in a dedicated COVID hospital: A longitudinal prospective study of 1000 patients.

Authors:  Arun Kumar Yadav; S Ghosh; Atul Kotwal; S K Kaushik; Saurabh Bobdey; Rajesh Sahu; Suraj Kapoor; D S Faujdar; Prabhakar T Teli; Vivek Anand
Journal:  Med J Armed Forces India       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.